Vaso Corporation Strengthens Ties with GE HealthCare
Vaso Corporation
137 Commercial Street
Plainview, New York 11803
Tel: (516) 997-4600 Fax: (516) 997-2299
Investor Contact:
Jonathan Newton
Investor Relations
Phone: 516-997-4600
Email: jnewton@vasocorporation.com
Vaso Corporation has announced a significant update concerning its collaboration with GE HealthCare, one of the leading innovators in the healthcare sector. This announcement centers around a recent extension of their existing sales representation agreement, further solidifying their partnership for the future.
Long-standing Partnership with GE HealthCare
By extending the sales representation agreement, Vaso Corporation continues its strategic commitment to providing advanced diagnostic imaging and ultrasound solutions. This extension is particularly noteworthy as it marks the fifth revision of the agreement, demonstrating the durable nature of this partnership that first began in May 2010. Over a decade of collaboration and dedication bodes well for both companies involved, positioning them as leaders in healthcare diagnostics.
Impact on Diagnostic Imaging Solutions
This agreement ensures that VasoHealthcare, a wholly owned subsidiary of Vaso Corporation, will maintain its role in representing GE HealthCare’s extensive portfolio. These products and services include a wide array of diagnostic imaging technologies such as computed tomography (CT), magnetic resonance imaging (MR), molecular imaging, X-ray systems, mammography, and interventional guided solutions. Such a diverse range indicates the depth of the collaboration and its potential impact on improving healthcare outcomes.
Moreover, the amendment reaffirms the alignment of both companies’ commercial strategies. By cooperating closely, they can leverage VasoHealthcare’s expertise alongside GE HealthCare’s innovative technologies to better serve healthcare providers throughout the nation.
Commitment to Patient Care
Catherine Estrampes, President & CEO, U.S. and Canada, GE HealthCare, highlighted the importance of this extension. She stated that it reflects the partnership's strength and shared commitment to advancing patient care in the United States. This sentiment conveys a shared vision of nurturing innovation in healthcare for a healthier future.
VasoHealthcare’s Role
Jane Moen, President of VasoHealthcare, echoed similar beliefs. She expressed that the partnership built on trust and shared goals provides customers with continuity and confidence in the products and services they receive. This initiative is focused on community hospitals, outpatient imaging centers, and practices in rural and underserved markets, emphasizing VasoHealthcare's mission to enhance healthcare service delivery.
Dr. Jun Ma, President and CEO of Vaso Corporation, remarked on the successful representation of GE HealthCare’s diagnostic imaging equipment and the expansion into ultrasound products. His acknowledgment of the team’s dedication underlines the internal commitment to excellence that Vaso Corporation stands for, further affirming the significance of this partnership.
What’s Next for Vaso Corporation?
As Vaso Corporation moves forward with its extended agreement, the company remains focused on its core operations across multiple sectors. Vaso Corporation operates through three key business arms. In addition to VasoHealthcare, it includes VasoTechnology, a leader in managed connectivity for healthcare, and VasoMedical, renowned for its proprietary medical device innovations and cloud-based services. This diversified business model positions the company to better address evolving healthcare challenges and provide comprehensive solutions across the board.
With the health technology landscape continually evolving, Vaso Corporation's dedication to improving outcomes through innovative partnerships and strategic planning is indeed a blueprint for success. The future looks promising as they navigate the complexities of healthcare needs while striving to cultivate a healthier tomorrow for all.
Frequently Asked Questions
What is the recent development involving Vaso Corporation and GE HealthCare?
Vaso Corporation has extended its sales representation agreement with GE HealthCare through December 31, 2030, emphasizing their long-standing partnership.
How long has the partnership between Vaso Corporation and GE HealthCare lasted?
The partnership began in May 2010, making this extension their fifth agreement and spanning over 20 years of collaboration.
What services does VasoHealthcare provide under this agreement?
VasoHealthcare represents GE HealthCare’s various diagnostic imaging and ultrasound products and services, including CT, MR, and X-ray solutions.
Who is the President & CEO of GE HealthCare?
Catherine Estrampes serves as the President & CEO for GE HealthCare in the U.S. and Canada.
What sectors does Vaso Corporation operate in?
Vaso Corporation operates through three core subsidiaries: VasoHealthcare, VasoTechnology, and VasoMedical, each serving different aspects of healthcare provision.
